Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

Candriam Equities B - Global Health

+ Add to Watchlist

CRE2489:BB

2,459.97 USD 11.28 0.46%

As of 00:59:30 ET on 03/02/2015.

Snapshot for Candriam Equities B - Global Health (CRE2489)

Year To Date: +6.77% 3-Month: +4.27% 3-Year: +23.00% 52-Week Range: 1,984.43 - 2,455.42
1-Month: +4.61% 1-Year: +17.68% 5-Year: +16.21% Beta vs MXWO0HC: 1.01

Mutual Fund Chart for CRE2489

No chart data available.
  • CRE2489:BB 2,459.97
  • 1M
  • 1Y
Interactive CRE2489 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for CRE2489

Candriam Equities B Global Health Care is an open-end fund registered in Belgium. The objective is long-term growth and risk management through diversification. The Fund invest predominantly in US and European stocks of the pharmaceutical, healthcare, and biotechnology sectors. The Fund may also invests in options, warrants and futures. The benchmark is the MSCI World Health C.

Inception Date: 06-04-1997 Telephone: -
Managers: RUDI VAN DEN EYNDE
Web Site: www.candriam.com

Fundamentals for CRE2489

NAV (on 2015-03-02) 2,459.97
Assets (M) (on 2015-03-02) 350.86
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for CRE2489

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2014-10-15) 23.80
Dividend Yield (ttm) 1.14

Fees & Expenses for CRE2489

Front Load 2.50
Back Load 0.00
Current Mgmt Fee 1.50
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.80

Top Fund Holdings for CRE2489

Filing Date: 01/30/2015
Name Position Value % of Total
Johnson & Johnson 200,000 20,028,000 5.786%
Novartis AG 198,000 19,400,785 5.605%
Roche Holding AG 58,000 15,671,750 4.528%
Merck & Co Inc 230,000 13,864,400 4.005%
Gilead Sciences Inc 121,000 12,684,430 3.665%
Pfizer Inc 400,000 12,500,000 3.611%
Medtronic PLC 130,592 9,324,269 2.694%
Sanofi 94,000 8,698,093 2.513%
GlaxoSmithKline PLC 390,000 8,592,820 2.482%
Bayer AG 59,000 8,525,383 2.463%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil